Better Therapeutics Inc

1
OTCPK:BTTX (USA)  
$ 0.01 0 (0%) 11:09 PM EST
At Loss
Market Cap:
$ 589.00K
Enterprise V:
$ 8.30M
Volume:
-
Avg Vol (2M):
303.11K
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
303.11K

Business Description

Description
Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases. The company has developed a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.46
Equity-to-Asset -0.93
Debt-to-Equity -1.44
Debt-to-EBITDA -0.54
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 48.28
9-Day RSI 50.58
14-Day RSI 50.1
6-1 Month Momentum % -96.75
12-1 Month Momentum % -99.11

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.57
Quick Ratio 0.57
Cash Ratio 0.51

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -0.4
Shareholder Yield % -408.83

Profitability Rank

Name Current Vs Industry Vs History
ROA % -182.93
ROIC % -317.61
ROC (Joel Greenblatt) % -25053.3
ROCE % -642.62

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.28
EV-to-EBITDA -0.31
EV-to-FCF -0.3
Earnings Yield (Greenblatt) % -357.14
FCF Yield % -4652.12

Financials (Next Earnings Date:2024-07-19 Est.)

BTTX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BTTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Better Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.15
Beta 0
Volatility % 117.51
14-Day RSI 50.1
14-Day ATR ($) 0.003795
20-Day SMA ($) 0.010486
12-1 Month Momentum % -99.11
52-Week Range ($) 0.005 - 0.81
Shares Outstanding (Mil) 54.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 1
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Better Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Better Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Better Therapeutics Inc Frequently Asked Questions

What is Better Therapeutics Inc(BTTX)'s stock price today?
The current price of BTTX is $0.01. The 52 week high of BTTX is $0.81 and 52 week low is $0.01.
When is next earnings date of Better Therapeutics Inc(BTTX)?
The next earnings date of Better Therapeutics Inc(BTTX) is 2024-07-19 Est..
Does Better Therapeutics Inc(BTTX) pay dividends? If so, how much?
Better Therapeutics Inc(BTTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1